Harvard Bioscience Inc reports results for the quarter ended in September - Earnings Summary

Harvard Bioscience

08/11/2022 22:02

* Harvard Bioscience Inc  HBIO.OQ  reported a quarterly
adjusted
loss of 1 cent​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was
for earnings of 7 cents per share.
    * Revenue fell 9.2% to $26.92 million from a year ago;
analysts
expected $28.89 million. 
    * Harvard Bioscience Inc's reported EPS for the quarter was
a loss
of 8 cents​.
    * The mean earnings estimate of analysts had risen by
about 11.1%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Harvard Bioscience Inc shares had fallen by 2.0% this
quarter and lost 64.4% so far this year.
    * The company reported a quarterly loss of $3.41 million.
    * Wall Street's median 12-month price target for Harvard
Bioscience Inc is $7.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 10:02 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      0.07           -0.01          Missed
 Jun. 30 2022      0.06           0.05           Missed
 Mar. 31 2022      0.05           0.04           Missed
 Dec. 31 2021      0.10           0.08           Missed